According to a new report by Polaris Market Research, the global Prostaglandin Analogs market was valued at USD 3,770.02 million in 2023 and is projected to reach USD 6,566.71 million by 2032, expanding at a CAGR of 6.4% over the forecast period. Growth is underpinned by the rising prevalence of glaucoma and other ophthalmic conditions, expanding drug formulation...